Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

A Tale Of Two Committees: Which Probed EpiPen Better?

Sep 27 2016

• By Derrick Gingery

Capitol House

Related Content

FDA Hiring Campaign Continues; Goal Is Addressing Pending ANDAs

Sep 27 2016

EpiPen Price Hearing: House Plays Bootleg Tape Of Shkreli Event

Sep 22 2016

EpiPen Generics: Woodcock Explains Injector Studies

Sep 22 2016

Mylan's EpiPen Nightmare Not Over Yet, But Will Congress Just Write?

Aug 30 2016

Why Generic EpiPen Is Not The Answer – Until FDA Says It Is

Aug 29 2016

Related Companies

Viatris Inc.

Vyera Pharmaceuticals, LLC

Bausch Health Companies Inc.

Additional Topics

United States Drug Review Pricing Debate Approvals Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window